ALT This image is a graph from a medical study titled "Sodium Bicarbonate for Critically Ill Adults with Metabolic Acidosis and Shock" published in the New England Journal of Medicine. The trial name (SODa-BIC) is in parentheses next to the title. The graph shows survival probability over 90 days for two groups: one receiving sodium bicarbonate and the other a placebo. The horizontal axis represents days since randomization, while the vertical axis represents the probability of survival, ranging from 0 to 1. A legend indicates the number of patients at risk over time for both groups.

ALT A graph from an article titled "Vasopressors or Fluids in Early Septic Shock," which was presented at the Critical Care Reviews Meeting. The trial name "ARISE FLUIDS" appears in parentheses with the title. The x-axis shows days 0 to 90, and the y-axis represents the percentage of patients. Two lines indicate the percentage for vasopressors and fluids.

ALT Graph comparing mean eGFR slopes between finerenone and placebo groups. The chart has three sections: Total, Baseline to Month 3, and Month 3 to End of Treatment. Numerical values are provided above the bars, showing treatment differences with confidence intervals.

ALT A line graph from an article published in the New England Journal of Medicine compares obinutuzumab and tacrolimus in treating primary membranous nephropathy over 104 weeks. The y-axis represents the percentage of patients relapse‑free, while the x-axis represents weeks. The graph shows two lines, one for obinutuzumab and another for tacrolimus. The image mentions the European Renal Association Congress at the top.